A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program

BACKGROUND: The Ibrance® Patient Program was established to provide access to palbociclib for UK National Health Service (NHS) patients with metastatic breast cancer (MBC), pending a funding decision. METHODS: Non-interventional cohort study involving a retrospective medical record review of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmieri, Carlo, Musson, Alison, Harper-Wynne, Catherine, Wheatley, Duncan, Bertelli, Gianfilippo, Macpherson, Iain R., Nathan, Mark, McDowall, Ellie, Bhojwani, Ajay, Verrill, Mark, Eva, Joe, Doody, Colm, Chowdhury, Ruhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449843/
https://www.ncbi.nlm.nih.gov/pubmed/37468569
http://dx.doi.org/10.1038/s41416-023-02352-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449843/
https://www.ncbi.nlm.nih.gov/pubmed/37468569
http://dx.doi.org/10.1038/s41416-023-02352-5

Ejemplares similares